← Back to Clinical Trials
Recruiting NCT06515717

NCT06515717 Exogenous Ketones and Behavior

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06515717
Status Recruiting
Phase
Sponsor German Institute of Human Nutrition
Condition Behavior
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2024-07-18
Primary Completion 2025-06-23

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 45 Years
Study Type INTERVENTIONAL
Interventions
ketone esterdextrose (placebo)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2024-07-18 with a primary completion date of 2025-06-23.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study will examine the effect of exogenous ketone ester on behavior and metabolism using Virtual Reality and computerizes behavioral tasks.

Eligibility Criteria

Inclusion Criteria: * Consent to participate * Fluent in German * Physically healthy. No regular medication * No drug use 1 week prior to the study * BMI 18-31 kg/m2 Exclusion Criteria: * Former or current illnesses of: * Brain or mind (including eating disorders, personality disorders, alcohol, drugs or drug dependence, neurological disorders other than occasional headache; depression or anxiety disorder excluded) * Heart or blood circulation * Gastro-intestinal or endocrine disorders * Liver or kidney disorders * Electrolyte imbalance * Other serious past or present medical conditions (for example, metabolic syndrome, diabetes, cancer) * Pregnancy * Extreme athletes (\>2h/day intense work-out; casual cycling or walking is ok) * Menopause (post menopause is ok) * Ketogenic diet, ketogenic supplement intake, intermittent fasting or calorie restricted diet during preceding 4 weeks of study participation * Fear of blood draw

Contact & Investigator

Central Contact

Beatrix Keweloh

✉ Beatrix.Keweloh@dife.de

📞 +49 33200 882518

Frequently Asked Questions

Who can join the NCT06515717 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06515717 currently recruiting?

Yes, NCT06515717 is actively recruiting participants. Contact the research team at Beatrix.Keweloh@dife.de for enrollment information.

Where is the NCT06515717 trial being conducted?

This trial is being conducted at Potsdam, Germany.

Who is sponsoring the NCT06515717 clinical trial?

NCT06515717 is sponsored by German Institute of Human Nutrition. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology